Usefulness of routine conventional cytogenetic analysis in tissues submitted for "lymphoma work-up"

Leukemia and Lymphoma

Volumn 49, Issue 1, 2008, Pages 75-80

  Dunphy, Cherie H ^a   Tang, Wozhan ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Sentara Virginia Beach General Hospital   (United States)

Author keywords

Clinical results; Cytogenetics; Lymphoma and Hodgkin disease; Marrow and stem cell transpantation; Neoplasia

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CHLOROMA; CHROMOSOME 6Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CHROMOSOME TRANSLOCATION 8; CLONAL VARIATION; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC VALUE; EXTRAMEDULLARY HEMATOPOIESIS; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPING; LYMPHADENITIS; LYMPHOID HYPERPLASIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SARCOMA;

CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; HUMANS; LYMPHOMA, NON-HODGKIN; RETROSPECTIVE STUDIES;

EID: 38549143139     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701684500     Document Type: Article

References (27)

1. Jaffe, E., Harris, N., Stein, H. and Vardiman, J. W. (2001) Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon, France
2. Cook, J. R., Shekter-Levin, S. and Swerdlow, S. H. (2004) Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas. Am J Clin Pathol, 121, pp. 826-835.
3. ISCN (1995) (1995) An International System for Human Cytogenetic Nomenclature, S. Karger, Basel
4. Berend, S. A., Canun, S., McCaskill, C., Page, S. L. and Shaffer, L. G. (1998) Molecular analysis of mosaicism for two different de novo acrocentric rearrangements demonstrates diversity in Robertsonian translocation formation. Am J Med Genetics, 80, pp. 252-259.
5. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A. and Bullinger, L. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med, 343, pp. 1910-1916.
6. Ripolles, L., Ortega, M., Ortuno, F., González, A., Losada, J. and Ojanguren, J. (2006) Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia. Cancer Genetics Cytogenetics, 171, pp. 57-64.
7. Dewald, G. W., Brockman, S. R., Paternoster, S. F., Bone, N. D., O'Fallon, J. R. and Allmer, C. (2003) Chromosome in situ hybridization: correlation with significant features of B-cell chronic lymphocytic leukaemia. Br J Haematol, 121, pp. 287-295.
8. Kern, W., Haferlach, T., Schnittger, S. and Schoch, C. (2005) Detection of t(14;18)(q32;q21) in B-cell chronic lymphocytic leukemia. Arch Path Lab Med, 129, pp. 410-411.
9. Dyer, M JS, Zani, V. J., Lu, W. Z., O'Byrne, A., Mould, S. and Chapman, R. (1994) BCL2 translocations in leukemias of mature B cells. Blood, 83, pp. 3682-3688.
10. Kojima, K., Taniwaki, M., Yoshino, T., Katayama, Y., Sunami, K. and Fukuda, S. (1998) Trisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia. Int J Hematol, 67, pp. 199-203.
11. Nowakowski, G. S., Dewald, G. W., Hoyer, J. D., Paternoster, S. F., Stockero, K. J. and Fink, S. R. (2005) Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol, 130, pp. 36-42.
12. Frater, J. L., Tsiftsakis, E., His, E., Pettay, J. and Tubbs, R. R. (2001) Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. Diagn Molec Path, 10, pp. 214-222.
13. Karnolsky, I. N. (2000) Cytogenetic abnormalities in chronic lymphocytic leukemia. Folia Med (Plovdiv), 42, pp. 5-10.
14. Athanasiadou, A., Stamatopoulos, K., Tsompanakou, A., Gaitatzi, M., Kalogiannidis, P. and Anagnostopoulos, A. (2006) Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis. Cancer Genet Cytogenet, 168, pp. 109-119.
15. Godon, A., Moreau, A., Talmant, P., Baranger-Papot, L., Geneviève, F. and Milpied, N. (2003) Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia, 17, pp. 255-259.
16. Horsman, D. E., Connors, J. M., Pantzar, T. and Gascoyne, R. D. (2001) Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer, 30, pp. 375-382.
17. Hoglund, M., Sehn, L., Connors, J. M., Gascoyne, R. D., Siebert, R. and Säil, T. (2004) Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer, 39, pp. 195-204.
18. Ott, G., Katzenberger, T., Lohrs, Kindelberger, S., Rüdiger, T. and Wilhelm, M. (2002) Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood, 99, pp. 3806-3812.
19. Bosga-Bouwer, A. G., van Imhoff, G. W., Boonstra, R., van der Veen, A., Haralambieva, E. and Berg, A van den (2003) Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: T(14;18) and 3q27 are mutually exclusive. Blood, 101, pp. 1149-1154.
20. Hsi, E. D., Mirza, I., Lozanski, G., Pohlman, B., Karafa, M. T. and Coupland, R. (2004) A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences. Arch Path Lab Med, 128, pp. 863-868.
21. de la Fouchardiere, A., Gazzo, S., Balme, B., Chouvet, B., Felman, P. and Coiffier, B. (2006) Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas. Am J Dermatopath, 28, pp. 287-292.
22. Voorhees, P. M., Carder, K. A., Smith, S. V., Ayscue, L. H., Rao, K. W. and Dunphy, C. H. (2004) Follicular lymphoma with a Burkitt translocation-predictor of an aggressive clinical course. Arch Path Lab Med, 128, pp. 210-213.
23. Lepretre, S., Buchonnet, G., Stamatoullas, A., Lenain, P., Duval, C. and d'Anjou, J. (2000) Chromosome abnormalities in peripheral T-cell lymphoma. Cancer Genet Cytogenet, 117, pp. 71-79.
24. McKhann, C. F. (1969) Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation, 8, pp. 209-212.
25. Chadburn, A., Chen, J. M., Hsu, D. T., Frizzera, G., Cesarman, E. and Garrett, T. J. (1998) The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer, 82, pp. 1978-1987.
26. Mourad, W. A., Tulabah, A. and Sayed, A Al (2006) The impact of the World Health Organization classification and clonality assessment of post-transplant lymphoproliferative disorders on disease management. Arch Pathol Lab Med, 130, pp. 1649-1653.
27. Liu, L. B., Liu, L. and Wang, X. B. (2005) Cytobiological and clinicobiological features of AML with 11q23 chromosome abnormalities. Zhongguo Shi Yan Xue Za Zhi, 13, pp. 932-936.